Fundraising Fox

ReveraGen BioPharma

Rockville, US · Delaware corporation

Biotech

Founders & leadership

KN
Kanneboyina NagarajuCo-founder
EP
Eric P. HoffmanCo-founder
JM
John M. McCallCo-founder
ML
May LiangNamed on SEC filing
EA
Elizabeth A. SingerNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$800K disclosed across 1 round · 2018

▶$800KraisedMar 2018 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • May LiangDirector
  • Kanneboyina NagarajuExecutive Officer, Director
  • Eric P. HoffmanExecutive Officer, Director
  • John M. McCallExecutive Officer, Director
  • Elizabeth A. SingerDirector
Offering amount
$2.5M
Amount sold
$800K
First sale
Feb 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Santhera Announces Completion of ReveraGen’s Long-Term Extension Study with Vamorolone in Duchenne Muscular Dystrophy - Jett Foundationjettfoundation.org · Jun 2020Partnerships - ReveraGen BioPharmareveragen.com · Jul 2016International Consortium Provides $2M Funding for Phase 1 Clinical Trial of ReveraGen DMD Drug | Muscular Dystrophy Associationmda.org · May 2016

Frequently asked questions

Who founded ReveraGen BioPharma?
ReveraGen BioPharma was founded by Kanneboyina Nagaraju, Eric P. Hoffman, John M. McCall.
How much funding has ReveraGen BioPharma raised?
ReveraGen BioPharma has disclosed $800K raised across 1 round.
Where is ReveraGen BioPharma headquartered?
ReveraGen BioPharma is headquartered in Rockville, US.